• 2024
• MayContracted Anti-cancer Drug Sensitivity Test Service, 'OncoSensi Test' (Lung cancer) with Yeouido St. Mary's Hospital
• MayContracted Anti-cancer Drug Sensitivity Test Service 'OncoSensi Test' (Ovarian Cancer) with Samsung Medical Center
• AprEstablishment of Clinical Research Lab at Charite Hospital in Berlin, Germany
• AprSelected as an Alternative Animal Technology Project by Korea, Ministry of Food and Drug Safety
• MarContracted Anti-cancer Drug Sensitivity Test Service, OncoSensi Test' (Lung cancer) with Seoul St. Mary's Hospital
• JauApproval for Lung Cancer Reagent Kit (Grade 1 declaration)

• 2023
• DecISO Certification 14001(environment), 37301(compliance with standards), 45001(Safety and Health), and 27001(Information Protection)
• DecExport of ASFA Spotters to Luxembourg Institute of Health (LIH) and Vanderbilt University Medical Center (US)
• DecClinical Trials for Products Approval in Ovarian Cancer and Head & neck Cancer (Korea, Ministry of Food and Drug Safety)
• NovAwarded for Distinguished Service in Research Industry (Korea, Minister of Science and ICT)
• NovRegistration of FDA Class I and US Medical Device Standard Code for ASFA Spotter V6.5 and ASFA Scanner V5.5
• JulCertification for Medical Service using "Multiple factor-based anti-cancer drug sensitivity test" (Korea, Health Insurance Review and Assessment Service)
• MaySelected as Korea Medical Device Development Fund Top 10 Project in 2023 (Head and Neck Cancer)
• MaySigned MOU with JW C&C New Drug Research Institute to develop innovative anticancer drugs using "cancer organoid diagnosis platform“
• AprSelected as a Clinical Trial Project by Korea Medical Device Development Fund for Head & Neck Cancer Radiosensitivity Test (2.6 years, 2.3 Billion Won)

• 2022
• DecWinner of Innoviz Technology Cooperation Outstanding Company / Medical Device Industry Development Merit Award
• NovGyeonggi-do Province's promising small and medium-sized enterprises / Small Business Management Innovation Award
• SepObtained GMP(Good manufacturing practices) certification
• AugSigned clinical contract to validate solutions for prognosis/prediction of personalized cancer treatment(GC Labs)
• JulReceived the Bio grand prize at KOREA Leading Company awards (4th consecutive years)
• MaySelected as a future leading research equipment business (Ministry of Science and ICT, 3.9 years, 7.64 billion won)(Organized)
• Mar Certification of excellent job invention compensation companies
• MarConfirmation and equivalence assessment for ‘ATP-Based Chemotherapy Response Assay’ (Health Insurance Review and Assessment Service)

• 2021
• DecAwarded the 2021 Venture Award(the corporate sector, the Minister of SMEs and Startups)
• NovTechnology innovation-oriented SMEs(Inno-Biz) Certification(the Ministry of SMEs and Startups)
• Oct"3 dimension cancer drug sensitivity" service(Health Insurance Review & Assessment Service)
• OctSelected as an international joint technology development project in 2021 years (Ministry of Trade, Industry and Energy, 3 years)
• SepKOREA Bio-Leading Company Grand prize(3 consecutive years)
• MarObtained CE certification(EC Declaration of Conformity, Phenotrack BCA)
• FebIPO representative organizer contract
• FebVC series B investment attraction (11.5 billion won)

• 2020
• DecEstablished a joint lab at Luxembourg Institute of Health (LIH)
• DecSelected as an advanced technology center institute in 2020 (Ministry of Science and ICT)
• DecSelected as a strategic start-up task(breast cancer) (Ministry of SMEs and Startups)
• SepSelected as a whole-cycle medical device research and development project(head and neck cancer/ovarian cancer) by Pan-government
• AugKOREA Bio-Leading Company Grand prize(2 consecutive years)
• JulSelected as a radiation high-value new material development project(Ministry of Science and ICT)
• JunObtained KFDA Medical device certification(Calcein AM Kit)
• MaySelected as a 2020 technology commercialization capability enhancement project (Ministry of Science and ICT)
• FebJoint development contract for rare cancer treatment based on AI Model (Azothbio)

• 2019
• DecAwarded Small and Medium Business excellence Partner Award (Korea Basic Science Institute)
• DecObtained IVD CE certification approval (ASFA^Ⓡ Scanner)
• NovObtained ISO 13485 certification
• SepGrand prize awarded as 2019 Korea Biology leading company
• SepObtained FDA medical device certification (ASFA^Ⓡ Spotter)
• JunAttend NIH Spring Exhibit 2019 (USA, Bethesda) Display/PR
• JunObtained FDA medical device certification (ASFA^Ⓡ Scanner)
• MaySelected as a start-up leap package business (Ministry of Health and Welfare)
• AprKFDA medical device manufacture and certification approval (ASFA^Ⓡ Scanner)
• FebSelected as an investment-related project for public technology transfer company (Ministry of Science and ICT)
• JanAttracting VC Series A investment (10 Billion won)

• 2018
• DecSet-up liver cancer patient personalized drug screening platform for the Precision medicine (Singapore)
• SepKsilink-LIH- MBD research collaboration agreement for personalized cancer drug screening
• JunSelected as a business growth technology development business (Ministry of SMEs and Startups)
• FebSLAS exhibition (USA, San Diego) Display /PR

• 2017
• OctSelected for military substitute service designated company(Military Manpower Administration)
• SepSelected as pharmaceutical biotechnology advanced technology business (Gyeonggido Business & Science Accelerator)
• SepSelected for industry-academic cooperation technology development project (Ministry of SMEs and Startups)
• JunAttracting VC seeding investment (2 Billion won)
• FebVenture capital certification
• JanSinged sales representative agreement with ThermoFisher Scientific
• JanSelected as KRISS family corporation and technology leading hidden champion training project (Korea Research Institute of Standards and Science)

• 2016
• DecSelected as KBSI family corporation (Korea Basic Science Institute)
• OctFrance Ksilink, Export 3D cell culture /drug screening device (First)

• 2015
• JanEstablished MBD Co., Ltd.